Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells

Adoptive immunotherapy with T cells expressing a tumor-specific chimeric T-cell receptor is a promising approach to cancer therapy that has not previously been explored for the treatment of lymphoma in human subjects. We report the results of a proof-of-concept clinical trial in which patients with...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Till, Brian G., Jensen, Michael C., Wang, Jinjuan, Chen, Eric Y., Wood, Brent L., Greisman, Harvey A., Qian, Xiaojun, James, Scott E., Raubitschek, Andrew, Forman, Stephen J., Gopal, Ajay K., Pagel, John M., Lindgren, Catherine G., Greenberg, Philip D., Riddell, Stanley R., Press, Oliver W.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Hematology 2008
Θέματα:
Clinical Trials and Observations
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2532803/
https://ncbi.nlm.nih.gov/pubmed/18509084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-12-128843
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια